Publications - Page 23 sur 57 - RespiFIL - Filière de santé des maladies respiratoires rares

Voici les publications scientifiques relatives aux maladies respiratoires rares auxquelles les membres de la filière ont contribué, classées par groupes de pathologies (depuis juillet 2021).

Dyskinésies ciliaires primitives (DCP)
Ear and upper airway clinical outcome measures for use in primary ciliary dyskinesia research: a scoping review.

Alexandru M, Veil R, Rubbo B, Goutaki M, Kim S, Lam YT, Nevoux J, Lucas JS, Papon JF.

Eur Respir Rev. 2023 Jul 12;32(169):220200.
Dyskinésies ciliaires primitives (DCP)
Early genetic analysis by next-generation sequencing improves diagnosis of primary ciliary dyskinesia.

Petrarca L, De Luca A, Nenna R, Hadchouel A, Mazza T, Conti MG, Masuelli L, Midulla F, Guida V.

Pediatr Pulmonol. 2023 Jul 21.
Dyskinésies ciliaires primitives (DCP)
Characteristics of Otologic Disease Among Patients With Primary Ciliary Dyskinesia.

Goutaki M, Lam YT, Alexandru M, Anagiotos A, Armengot M, Boon M, Burgess A, Caversaccio N, Crowley S, Dheyauldeen SAD, Emiralioglu N, Erdem E, van Gogh C, Gunaydin O, Haarman EG, Harris A, Hayn I, Ismail-Koch H, Karadag B, Kempeneers C, Kim S, Lorent N, Ozcelik U, Pioch C, Poirrier AML, Reula A, Roehmel J, Yiallouros P, Yumusakhuylu AC, Papon JF.

JAMA Otolaryngol Head Neck Surg. 2023 Jul 1;149(7):587-596.
Dyskinésies ciliaires primitives (DCP)
Sinonasal disease among patients with primary ciliary dyskinesia: an international study.

Lam YT, Papon JF, Alexandru M, Anagiotos A, Armengot M, Boon M, Burgess A, Crowley S, Dheyauldeen SAD, Emiralioglu N, Erdem Eralp E, van Gogh C, Gokdemir Y, Gunaydın O, Haarman EG, Harris A, Hayn I, Ismail-Koch H, Karadag B, Kempeneers C, Kim S, Latzin P, Lorent N, Ozcelik U, Pioch C, Poirrier AML, Reula A, Roehmel J, Yiallouros P; EPIC-PCD team; Goutaki M; EPIC-PCD team:.

ERJ Open Res. 2023 May 22;9(3):00701-2022.
Dyskinésies ciliaires primitives (DCP)
Lung Transplantation for Primary Ciliary Dyskinesia and Kartagener Syndrome: A Multicenter Study.

Marro M, Leiva-Juárez MM, D'Ovidio F, Chan J, Van Raemdonck D, Ceulemans LJ, Moreno P, Kindelan AA, Krueger T, Koutsokera A, Ehrsam JP, Inci I, Yazicioglu A, Yekeler E, Boffini M, Brioude G, Thomas PA, Pizanis N, Aigner C, Schiavon M, Rea F, Anile M, Venuta F, Keshavjee S.

Transpl Int. 2023 Feb 14;36:10819.
Fibrose pulmonaire - FPI
Design of a phase III, double-blind, randomised, placebo-controlled trial of BI 1015550 in patients with idiopathic pulmonary fibrosis (FIBRONEER-IPF).

Richeldi L, Azuma A, Cottin V, Kreuter M, Maher TM, Martinez FJ, Oldham JM, Valenzuela C, Gordat M, Liu Y, Stowasser S, Zoz DF, Wijsenbeek MS.

BMJ Open Respir Res. 2023 Aug;10(1):e001563.
Fibrose pulmonaire - FPI
Ziritaxestat, a Novel Autotaxin Inhibitor, and Lung Function in Idiopathic Pulmonary Fibrosis: The ISABELA 1 and 2 Randomized Clinical Trials.

Maher TM, Ford P, Brown KK, Costabel U, Cottin V, Danoff SK, Groenveld I, Helmer E, Jenkins RG, Milner J, Molenberghs G, Penninckx B, Randall MJ, Van Den Blink B, Fieuw A, Vandenrijn C, Rocak S, Seghers I, Shao L, Taneja A, Jentsch G, Watkins TR, Wuyts WA, Kreuter M, Verbruggen N, Prasad N, Wijsenbeek MS; ISABELA 1 and 2 Investigators.

JAMA. 2023 May 9;329(18):1567-1578.
Sarcoïdose
Efficacy and safety of methylprednisolone pulse followed by oral prednisone vs. oral prednisone alone in sarcoidosis tubulointerstitial nephritis: a randomized, open-label, controlled clinical trial.

Mahevas M, Audard V, Rousseau A, Cez A, Guerrot D, Verhelst D, Delahousse M, Hanrotel C, Pillebout E, Daugas E, Krastinova E, Valeyre D, Boffa JJ; GSF French Sarcoidosis Group.

Nephrol Dial Transplant. 2023 Mar 31;38(4):961-968.
Pneumopathies interstitielles diffuses (PID)
The world of rare interstitial lung diseases.

Buschulte K, Cottin V, Wijsenbeek M, Kreuter M, Diesler R.

Eur Respir Rev. 2023 Feb 7;32(167):220161.
Pneumopathies interstitielles diffuses (PID)
Occupational interstitial lung diseases.

Spagnolo P, Ryerson CJ, Guler S, Feary J, Churg A, Fontenot AP, Piciucchi S, Udwadia Z, Corte TJ, Wuyts WA, Johannson KA, Cottin V.

J Intern Med. 2023 Aug 3.

FILTRER :

Par mot clé

Par maladies

Réinitialiser les filtres

Ear and upper airway clinical outcome measures for use in primary ciliary dyskinesia research: a scoping review.

Early genetic analysis by next-generation sequencing improves diagnosis of primary ciliary dyskinesia.

Characteristics of Otologic Disease Among Patients With Primary Ciliary Dyskinesia.

Sinonasal disease among patients with primary ciliary dyskinesia: an international study.

Lung Transplantation for Primary Ciliary Dyskinesia and Kartagener Syndrome: A Multicenter Study.

Design of a phase III, double-blind, randomised, placebo-controlled trial of BI 1015550 in patients with idiopathic pulmonary fibrosis (FIBRONEER-IPF).

Ziritaxestat, a Novel Autotaxin Inhibitor, and Lung Function in Idiopathic Pulmonary Fibrosis: The ISABELA 1 and 2 Randomized Clinical Trials.

Efficacy and safety of methylprednisolone pulse followed by oral prednisone vs. oral prednisone alone in sarcoidosis tubulointerstitial nephritis: a randomized, open-label, controlled clinical trial.

The world of rare interstitial lung diseases.

Occupational interstitial lung diseases.